Literature DB >> 25397868

Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.

Hirotsugu Kurobe1, Shuhei Tara1, Mark W Maxfield2, Kevin A Rocco2, Paul S Bagi2, Tai Yi1, Brooks V Udelsman2, Ethan W Dean2, Ramak Khosravi2, Heather M Powell3, Toshiharu Shinoka1,4, Christopher K Breuer1,4.   

Abstract

Our approach for fabricating tissue-engineered vascular grafts (TEVG), applied in the surgical management of congenital heart disease, is accomplished by seeding isolated bone marrow-derived mononuclear cells (BM-MNCs) onto biodegradable scaffolds. The current method used for isolation of BM-MNCs is density centrifugation in Ficoll. This is a time-consuming, labor-intensive, and operator-dependent method. We previously demonstrated that a simpler, faster, and operator-independent method for isolating BM-MNCs using a filter elution technique was feasible. In this study, we compare the use of each technique to determine if the BM-MNCs isolated by the filtration elution method are biologically equivalent to BM-MNCs isolated using density centrifugation. Scaffolds were constructed from a nonwoven poly(glycolic acid) fiber mesh coated with 50:50 poly(l-lactide-co-ɛ-caprolactone) sealant. BM-MNCs were isolated from the bone marrow of syngeneic C57BL/6 mice by either density centrifugation with Ficoll or filtration (Ficoll vs. Filter), then statically seeded onto scaffolds, and incubated overnight. The TEVG were implanted in 10-week-old C57BL/6 mice (n=23 for each group) as inferior vena cava interposition grafts and explanted at 14 days for analysis. At 14 days after implantation, there were no significant differences in graft patency between groups (Ficoll: 87% vs. Filter: 78%, p=0.45). Morphometric analysis by hematoxylin and eosin staining showed no difference of graft luminal diameter or neointimal thickness between groups (luminal diameter, Ficoll: 620.3±82.9 μm vs. Filter: 633.3±131.0 μm, p=0.72; neointimal thickness, Ficoll: 37.9±7.8 μm vs. Filter: 37.9±11.2 μm, p=0.99). Histologic examination demonstrated similar degrees of cellular infiltration and extracellular matrix deposition, and endothelial cell coverage on the luminal surface, in either group. Macrophage infiltration showed no difference in the number of F4/80-positive cells or macrophage phenotypes between the two experimental groups (Ficoll: 2041±1048 cells/mm(2) vs. Filter: 1887±907.7 cells/mm(2), p=0.18). We confirmed the biological equivalence of BM-MNCs, isolated using either density centrifugation or filtration, for making TEVG.

Entities:  

Mesh:

Year:  2014        PMID: 25397868      PMCID: PMC4442596          DOI: 10.1089/ten.TEC.2014.0442

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  14 in total

1.  Transplantation of a tissue-engineered pulmonary artery.

Authors:  T Shin'oka; Y Imai; Y Ikada
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Regulatory functions of the vascular endothelium.

Authors:  J R Vane; E E Anggård; R M Botting
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

Review 3.  Vascular extracellular matrix and arterial mechanics.

Authors:  Jessica E Wagenseil; Robert P Mecham
Journal:  Physiol Rev       Date:  2009-07       Impact factor: 37.312

4.  Development of an operator-independent method for seeding tissue-engineered vascular grafts.

Authors:  Brooks Udelsman; Narutoshi Hibino; Gustavo A Villalona; Edward McGillicuddy; Alejandro Nieponice; Yuki Sakamoto; Shojiro Matsuda; David A Vorp; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2011-05-06       Impact factor: 3.056

5.  Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular grafts.

Authors:  Hirotsugu Kurobe; Mark W Maxfield; Yuji Naito; Muriel Cleary; Mitchel R Stacy; Daniel Solomon; Kevin A Rocco; Shuhei Tara; Avione Y Lee; Albert J Sinusas; Edward L Snyder; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2015-01       Impact factor: 3.056

6.  A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts.

Authors:  Narutoshi Hibino; Tai Yi; Daniel R Duncan; Animesh Rathore; Ethan Dean; Yuji Naito; Alan Dardik; Themis Kyriakides; Joseph Madri; Jordan S Pober; Toshiharu Shinoka; Christopher K Breuer
Journal:  FASEB J       Date:  2011-08-24       Impact factor: 5.191

7.  Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.

Authors:  Narutoshi Hibino; Ani Nalbandian; Lesley Devine; Rajendra Sawh Martinez; Edward McGillicuddy; Tai Yi; Safa Karandish; Girolamo A Ortolano; Toshiharu Shin'oka; Edward Snyder; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2011-07-01       Impact factor: 3.056

8.  Blood donor white blood cell reduction filters as a source of human peripheral blood-derived endothelial progenitor cells.

Authors:  Amylynn A Teleron; Brian Carlson; Pampee P Young
Journal:  Transfusion       Date:  2005-01       Impact factor: 3.157

9.  Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Authors:  Jason D Roh; Gregory N Nelson; Matthew P Brennan; Tamar L Mirensky; Tai Yi; Tyrone F Hazlett; George Tellides; Albert J Sinusas; Jordan S Pober; W M Saltzman; Themis R Kyriakides; Christopher K Breuer
Journal:  Biomaterials       Date:  2007-12-27       Impact factor: 12.479

10.  Late-term results of tissue-engineered vascular grafts in humans.

Authors:  Narutoshi Hibino; Edward McGillicuddy; Goki Matsumura; Yuki Ichihara; Yuji Naito; Christopher Breuer; Toshiharu Shinoka
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

View more
  10 in total

1.  Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

Authors:  Takuma Fukunishi; Cameron A Best; Chin Siang Ong; Tyler Groehl; James Reinhardt; Tai Yi; Hideki Miyachi; Huaitao Zhang; Toshiharu Shinoka; Christopher K Breuer; Jed Johnson; Narutoshi Hibino
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

2.  Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time.

Authors:  Yong-Ung Lee; Nathan Mahler; Cameron A Best; Shuhei Tara; Tadahisa Sugiura; Avione Y Lee; Tai Yi; Narutoshi Hibino; Toshiharu Shinoka; Christopher Breuer
Journal:  Regen Med       Date:  2016-02-29       Impact factor: 3.806

3.  Factors Influencing Poor Outcomes in Synthetic Tissue-Engineered Tracheal Replacement.

Authors:  Victoria Pepper; Cameron A Best; Kaila Buckley; Cynthia Schwartz; Ekene Onwuka; Nakesha King; Audrey White; Sayali Dharmadhikari; Susan D Reynolds; Jed Johnson; Jonathan Grischkan; Christopher K Breuer; Tendy Chiang
Journal:  Otolaryngol Head Neck Surg       Date:  2019-04-30       Impact factor: 3.497

Review 4.  Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells.

Authors:  Lunchang Wang; Jiang Hu; Claire E Sorek; Eugene Y Chen; Peter X Ma; Bo Yang
Journal:  Expert Opin Biol Ther       Date:  2015-12-08       Impact factor: 4.388

5.  Effect of cell seeding on neotissue formation in a tissue engineered trachea.

Authors:  Elizabeth S Clark; Cameron Best; Ekene Onwuka; Tadahisa Sugiura; Nathan Mahler; Brad Bolon; Andrew Niehaus; Iyore James; Narutoshi Hibino; Toshiharu Shinoka; Jed Johnson; Christopher K Breuer
Journal:  J Pediatr Surg       Date:  2015-10-22       Impact factor: 2.545

6.  Comparison of Candidate Cell Populations for the Recellularization of Decellularized Heart Valves.

Authors:  Mitchell VeDepo; Eric Buse; Arghya Paul; Richard Hopkins; Gabriel Converse
Journal:  Cell Mol Bioeng       Date:  2018-04-30       Impact factor: 2.321

7.  Extended bioreactor conditioning of mononuclear cell-seeded heart valve scaffolds.

Authors:  Mitchell VeDepo; Eric Buse; Rachael Quinn; Richard Hopkins; Gabriel Converse
Journal:  J Tissue Eng       Date:  2018-04-10       Impact factor: 7.813

8.  Toward a patient-specific tissue engineered vascular graft.

Authors:  Cameron Best; Robert Strouse; Kan Hor; Victoria Pepper; Amy Tipton; John Kelly; Toshiharu Shinoka; Christopher Breuer
Journal:  J Tissue Eng       Date:  2018-03-16       Impact factor: 7.813

Review 9.  Current Progress in Vascular Engineering and Its Clinical Applications.

Authors:  Hatem Jouda; Luis Larrea Murillo; Tao Wang
Journal:  Cells       Date:  2022-01-31       Impact factor: 6.600

Review 10.  Future Perspectives on the Role of Stem Cells and Extracellular Vesicles in Vascular Tissue Regeneration.

Authors:  Eoghan M Cunnane; Justin S Weinbaum; Fergal J O'Brien; David A Vorp
Journal:  Front Cardiovasc Med       Date:  2018-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.